Copyright
©The Author(s) 2015.
World J Gastroenterol. Jul 21, 2015; 21(27): 8314-8325
Published online Jul 21, 2015. doi: 10.3748/wjg.v21.i27.8314
Published online Jul 21, 2015. doi: 10.3748/wjg.v21.i27.8314
Group (n = 6) | HMGB1 | NF-κB | MyD88 | TRIF |
Sham | 1.04 ± 0.19 | 1.03 ± 0.21 | 1.01 ± 0.10 | 1.01 ± 0.11 |
Control | 2.67 ± 0.30a | 2.04 ± 0.29a | 2.55 ± 0.16a | 3.05 ± 0.10a |
Anti-HMGB1 | 1.89 ± 0.18ab | 1.42 ± 0.23ab | 2.37 ± 0.08ab | 2.90 ± 0.13ab |
Anti-MyD88 | 2.35 ± 0.31abc | 1.77 ± 0.18abc | 2.30 ± 0.16ab | 3.04 ± 0.13ac |
Anti-TRIF | 2.29 ± 0.28abc | 1.70 ± 0.13abc | 2.53 ± 0.07acd | 2.85 ± 0.12abd |
- Citation: Wang J, He GZ, Wang YK, Zhu QK, Chen W, Guo T. TLR4-HMGB1-, MyD88- and TRIF-dependent signaling in mouse intestinal ischemia/reperfusion injury. World J Gastroenterol 2015; 21(27): 8314-8325
- URL: https://www.wjgnet.com/1007-9327/full/v21/i27/8314.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i27.8314